Chronic kidney disease linked to 95% increased risk of heart attack, finds Mayo Clinic study

ROCHESTER, Minn. -- Chronic kidney disease is associated with an increased risk of heart attack and other adverse cardiovascular outcomes, according to new research from Mayo Clinic. According to the study, the results regarding heart attack were especially striking: Chronic kidney disease was associated with a 95% increased risk of a heart attack during the follow-up period. The study has been published in Mayo Clinic Proceedings.

Chronic kidney disease afflicts an estimated 6.4% of U.S. adults 45 and older with a poor prognosis. Cardiovascular disease long has been identified as the major cause of premature death for chronic kidney disease patients, but this was believed to be due in part to common risk factors, such as hypertension and diabetes. However, there's growing evidence that impaired kidney function alone is a risk factor.

"Our study highlights the strong association between chronic kidney disease and heart disease, with evidence that patients with kidney disease are at an increased risk for heart attacks, heart failure, stroke, and even death," says Shravya Vinnakota, M.B.B.S., a resident in cardiovascular disease at Mayo Clinic College of Medicine and Science and the study's lead author.

The retrospective review of 1,981 patients who were treated for chronic kidney disease at Mayo Clinic between 1997 and 2000 found that over a 10.2-year follow-up period, these patients had significantly elevated cardiac biomarkers, and were at increased risk of heart attack, congestive heart failure, stroke and other adverse cardiovascular events.

The study analyzed data from the Olmsted County, Minn., Heart Function Study, a population-based random sample of 2,042 county residents 45 and older, and it used one of the longest follow-up periods in chronic kidney disease research.

The elevated biomarkers identified in the study -- the hormone NT-proBNP, which is produced by the heart, and the protein called high-sensitivity troponin, which is found in heart muscle cells -- may help identify chronic kidney disease patients who are at high risk, according to the study. Both biomarkers can be measured through blood tests, and these blood tests would give doctors and patients more information to manage risk factors, such as weight, blood pressure, high cholesterol and diabetes.

"Chronic kidney disease is widely prevalent, and its association with cardiovascular diseases and mortality is well-documented, says Horng Chen, M.D., a Mayo Clinic cardiologist who specializes in heart failure. "Despite this, there is a paucity of data that helps identify the patients with kidney disease who are at an increased cardiovascular risk. With this study, we have attempted to classify patients according to their kidney function, and analyze their cardiovascular outcomes and biomarker activation trends."

Further studies, including clinical trials, are needed to confirm the prognostic value of the cardiac biomarkers and the effectiveness of risk modification strategies, says Dr Chen, the study's senior supervising author.

For further reference log on to :

Journal Information: Mayo Clinic Proceedings